CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
CD206靶向脂质体髓鞘碱性蛋白肽治疗对一线疾病修饰疗法耐药的多发性硬化症患者：一项首次人体概念验证剂量递增研究
期刊:Neurotherapeutics
影响因子:6.9
doi:10.1007/s13311-016-0448-0
Belogurov, Alexey Jr; Zakharov, Konstantin; Lomakin, Yakov; Surkov, Kirill; Avtushenko, Sergey; Kruglyakov, Peter; Smirnov, Ivan; Makshakov, Gleb; Lockshin, Curtis; Gregoriadis, Gregory; Genkin, Dmitry; Gabibov, Alexander; Evdoshenko, Evgeniy
CD206
神经科学
多发性硬化症
CD20
Human
CD2
